This Cochrane Clinical Answer evaluates selective serotonin reuptake inhibitors (SSRI) improve outcomes in people recovering from a stroke.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.